Selective tumor treatment: β-galactosidase releases active agent from prodrugs
(Phys.org)—One of the largest challenges of chemotherapy lies in the fact that cancer cells must be killed while healthy tissue must be protected. French researchers have now introduced a new approach in the journal Angewandte ...